Immunotherapy for medullary thyroid carcinoma by a replication- defective adenovirus transducing murine interleukin-2

Endocrinology

Volumn 139, Issue 2, 1998, Pages 601-608

  Zhang, Rusheng ^a   Minemura, Kesami ^a   De Groot, Leslie J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE TRANSFER; HUMAN; HUMAN CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; THYROID MEDULLARY CARCINOMA; THYROID PARAFOLLICULAR CELL; TUMOR REJECTION;

EID: 0031732761     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.139.2.5764     Document Type: Article

References (47)

1. Abbas AK, Lichtman AH, Pober JS 1994 Cytokines. In: Abbas AK, Lichtman AH, Pober JS (eds) Cellular and Molecular Immunology. Saunders, Philadelphia, pp 251-252
2. Moller G 1980 T-cell stimulating factors. Immunol Rev 51:338-357
3. + lymphocytes during virus infection in vitro. J Immunol 142:1287-1292
4. Mosmann TR, Coffman RL 1987 Two types of mouse helper T-cell clones. Immunol Today 8:223
5. Grimm EA, Mazumder A, Zhang HZ, Rosenberg SA 1982 The lymphokine and activated killer cell phenomenon lysis of natural killer resistant fresh solid tumor cells by interleukin-2 activated autologous human peripheral blood lymphocytes. J Exp Med 155:1823-1841
6. Trinchierl G 1989 Biology of natural killer cells. Adv Immunol 47:187-376
7. Rosenberg SA 1988 Immunotherapy of cancer using interleukin-2. Current status and future prospects, Immunol Today 9:58-62
8. Lotze MT, Chang AE, Seipp AA, Simpson C, Vetto JT, Rosenberg SA 1986 High-dose recombinant interleukin 2 in the treatment of patients with disseminated cancer. JAMA 526:3117-3124
9. Sarna G, Collins J, Figlin R, Robertson P, Altrock B, Abels R 1990 Pilot study of introlymphotic interleukin-2 clinical and biological effects. J Biol Resp Modifiers 9:81-86
10. Gansbacher B, Zier K, Daniels B, Cronin K, Bannerji R, Gilboa E 1990 Interleukin 2 gene transfer into tumor cells abrogated tumorigenicity and induces protective immunity. J Exp Med 172:1217-1224
11. Fearon ER, Pardoll DM, Itaya T, Golumbek P, Levitky HI, Simons JW, Karasuyama H, Vogelstein B, Frost P 1990 Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell 60:397-403
12. Ohe Y, Podack ER, Olsen KJ, Miyahara Y, Ohira T, Miura K, Nishio K, Saijo N 1993 Combination effect of vaccination with IL2 and IL4 cDNA tranfected cells on the induction of a therapeutic immune response against Lewis lung carcinoma cells. Int J Cancer 53:432-437
13. Colombo MP, Rodolfo M 1995 Tumor cells engineered to produce cvtokines or cofactors as cellular vaccine: do animal studies really support clinical trials? Cancer Immunol Immunother 41:265-270
14. Musiani P, Allione A, Modica A, Lollini PL, Giovarelli M, Cavallo F, Belardelli F, Forni G, Modesti A 1996 Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-α, IFN-γ, and TNF-α. Lab Invest 74:146-157
15. Arienti F, Sule-Sulo J, Melani C, Maccalli C, Belli F, Illeni MT, Anichini A, Cascinelli N, Colombo MP, Parmiani G 1994 Interleukin-2 gene transduced human melanoma cells efficiently stimulate MHC-unrestricted and MHC-restricted autologous lymphocytes. Hum Gene Ther 5:1139-1150
16. Fakhrai H, Shawler DL, Gjerset R, Naviaux RK, Koziol J, Royston I, Sobol RE 1995 Cytokine gene therapy with interleukin-2-transduced fibroblasts: effects of IL-2 dose on anti-tumor immunity. Hum Gene Ther 6: 591-601
17. +8 T cells against the wild-type tumor: correlation with antigen presentation capability. J Exp Med 175:1423-1431
18. Jolly DJ, Willis RC, Friedmann T 1986 variable stability of selectable provirus after retroviral transfer into human cells. Mol Cell Biol 6:1141-1147
19. Temin HM 1989 Retrovirus vectors: promise and reality. Science 246:983
20. Temin HP 1986 Retrovirus vectors for gene transfer, efficient integration into, and expression of exogenous DNA in vertebrate cell genomes. In: Kucherlapati R (ed) Gene Transfer. Plenum Press, New York, pp 149-187
21. Akli S, Caillaud C, Vigne E, Stratford-Perricaudet LD, Poenaru L, Perricaudet M, Kahn A, Peschanski MR 1993 Transfer of a foreign gene into brain using adenovirus vectors. Nat Genet 3:224-228
22. Ilan Y, Prakash R, Davidson A, Jona V, Droguett G, Horwitz MS, Chowdhurg NR, Chowdhurg JR 1997 Oral tolerization to adenovirual antigens permits long-term gene expression using recombinant adenoviral vectors. J Clin Invest 99:1098-1106
23. Cordier L, Duffour M-T, Sabourin J-C, Lee MG, Cabannes J, Ragot T, Perricaudet M, Haddada H 1995 complete recovery of mice from a pre-established tumor by direct introtumoral delivery of an adenovirus vector harboring the murine IL-2 gene. Gene Ther 2:16-21
24. Omalley Jr BW, Cpoe KA, Chen S-H, Li D, Schwartz MR, Woo SLC 1996 Combination gene therapy for oral cancer in a murine model. Cancer Res 56:1737-1741
25. Randrianarison-Jewtowkoff V, Perricaudet M 1995 Recombinant adenoviruses as vaccines. Biologicals 23:145-157
26. Horowitz MS 1990 Adeniviridae and their replication. In: Field BN, Knipe DM, Chanock RM, Hirsch MS, Melnick JL, Monath TP, Roizman B (eds) Virology, ed 2. Raven Press, New York, pp 1679-1723
27. Marsh DJ, Learoyd DL, Robinson BG 1995 Medullary thyroid carcinoma: recent advances and management update. Thyroid 5:407-424
28. Graham FL 1984 Covalently closed circles of human adenovirus DNA are infectious. EMBO J 3:2917-2922
29. McGrory WJ, Bautista DS, Graham FL 1988 A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. Virology 163:614-617
30. Hitt M, Bett AJ, Addison CL, Precec L, Graham FL 1995 In: Adolph KW (ed) Methods in Molecular Genetics. Academic Press, Orlando, vol 78:13-30
31. Graham FL, Vandereb EJ 1973 A new technique for the assay of infective human adenovirus 5 DNA. Virology 52:456-467
32. Graham FL, Smiley J, Russell WC, Nairn R 1977 Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36:59-72
33. Davis LS, Lipsky PE, Bottomly K 1994 Measurement of human and murine interleukin-2 and interleukin-4. In: Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W (eds) Current Protocols in Immunology. Wiley and Sons, vol 1:6.3.1-6.3.13
34. Stratford-Perricaudet LD, Makeh I, Perricaudet M, Briand P 1992 Widespread long-term gene transfer to mouse skeletal muscles and heart. J Clin Invest 90:626-630
35. Sanes JR, Rubenstein JLR, Nicolas J-F 1986 Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos. EMBO J 5:3133-3142
36. Chen L, Linsley PS, Hellstrom KE 1993 Costimulation of T cells for tumor immunity. Immunol Today 14:483-486
37. Colombo MP, Modesti A, Parmiani G, Forni G 1992 Local cytokine availability elicits tumor rejection and systemic immunity through granulocyte-T-lymphcyte cross talk. Cancer Res 52:4853
38. Colombo MP, Forni G 1994 Cytokine gene transfer in tumor inhibition and tentative tumor therapy. Where are we now? Immunol Today 15:48
39. Colombo MP, Monica Rodolfo 1995 Tumor cells engineered to produce cytokines or co-factors as cellular vaccines: do animal studies really support clinical trials? Cancer Immunol Immunother 41:265-270
40. Brunda MJ, Luistro L, Rumennik L, Wright RB, Dvorozniak M, Aglione A, Wigginton JM, Wiltrout RH, Hendrzak JA, Palleroni AV 1996 Antitumor activity of interleukin 12 in preclinical models. Cancer Chemother Pharmacol [Suppl] 38:S16-S21
41. Couffinhal T, Kearney M, Sullivan A, Silver M, Tsurumi Y, Isner JM 1997 Histochemical staining following lacZ gene transfer underestimates transfection efficiency. Hum Gene Ther 8:929-934
42. Abbas AK, Lichtman AH, Pober JS 1994 Natural killer cells. In: Abbas AK, Lichtman AH, Pober JS (eds) Cellular and Molecular Immunology. Saunders, Philadephia, pp 274-276
43. Baskar S 1996 Gene-modified tumor cells as cellular vaccine. Cancer Immunol Immunother 43:165-173
44. O'Malley Jr BW, Sewell DA, Li D, Kosai K-i, Chen S-h, Woo SLC, Duan L 1997 The role of interleukin-2 in combination adenovirus gene therapy for head and neck cancer. Mol Endocrinol 11:667-673
45. Chen S-H, Kosai K-i, Xu B, Pham-Nguyen K, Contant C, Finegoid MJ, Woo SLC 1996 Combination suicide and cytokine gene therapy for hepatic metastases of colon carcinoma: sustained antitumor immunity prolongs animal survival. Cancer Res 56:3758-3762
46. O'Malley Jr BW, Cope KA, Chen S-h, Li D, Schwartz MR, Woo SLC 1996 Combination gene therapy for oral cancer in a murine model. Cancer Res 56:1737-1741
47. Wigginton JM, Komschlies KL, Back TC, Franco JL, Brunda MJ, Wiltrout RH 1996 Administration of interleukin 12 with pulse interleukin 2 and the rapid and complete eradication of murine renal carcinoma. J Natl Cancer Inst 88: 38-43